(Q28236159)

English

Denosumab: anti-RANKL antibody

scientific article (publication date: March 2009)

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Denosumab: anti-RANKL antibody (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Paul D Miller

1

0 references

language of work or name

0 references

publication date

March 2009

0 references

Current osteoporosis reports

1 reference

7

0 references

1

0 references

18-22

0 references

Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS11914-009-0004-5

21 January 2018

Remodeling and skeletal fragility

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoclast differentiation and activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of disease: is osteoporosis the obesity of bone?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PTH differentially regulates expression of RANKL and OPG.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Model structure and control of bone remodeling: a theoretical study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone and fat connection in aging bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteocytes: a proposed multifunctional bone cell.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteocytes, mechanosensing and Wnt signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wnt signaling: a win for bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Denosumab in postmenopausal women with low bone mineral density

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone's mechanostat: A 2003 update

1 reference

https://pubmed.ncbi.nlm.nih.gov/19239825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11914-009-0004-5

0 references

Dimensions Publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28236159&oldid=2177525358"